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Abstract
Among anterior mediastinal lesions, thymoma is the most common. Thymomas are tumors of thymic epithelial cell
origin that are distinguished by inconsistent histological and biologic behavior. Chest imaging studies typically
show a round or lobulated tumor in the anterior mediastinum. Calcifications in thymomas are classically punctuate
or amorphous, positioned within the lesion. Chest computed tomography (CT) features suggesting higher risk
thymoma consist of tumor heterogeneity, vascular involvement, lobulation, pulmonary nodules, lymphadenopathy,
and pleural manifestations. Imaging findings have an imperfect ability to predict stage and prognosis for thymoma
patients. Our objective is to highlight the clinical implications of thymoma calcifications on the diagnosis, clinical
manifestation and prognosis. A pubmed and google search was performed using the following words: thymoma
calcification, calcified thymus, mediastinal calcification, anterior mediastinal calcification, and calcified thymoma.
After reviewing 370 articles, 32 eligible articles describing thymoma calcifications were found and included in this
review. Although the presence of thymus calcifications was more common in patients with invasive thymomas,
they were present in significant portion of non-invasive thymomas. The presence of calcifications was not a
significant factor in differentiating between benign and malignant thymoma. As a result, the type, location, size or
other characteristics of thymus gland calcifications were not relevant features in clinical and radiologic diagnosis of
thymoma. The histopathological diagnosis is still the only possible way to confirm the neoplastic nature of
thymoma. All types of thymomas should be evaluated and managed independently of the presence of
calcifications.
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Introduction
The thymus gland is located in the anterior mediastinal
compartment of the chest. It originates from the third
and fourth branchial pouches and is composed from all
three germinal layers. The thymus gland is mostly active
in the pre-adolescent period and it the largest in size. It
starts to coalesce and becomes completely atrophic with
remnant adipose tissue by the late teens. Nonetheless,
lymphopoiesis of the T cells continues during adult life.
Tumors of the thymus gland are the most commonly
encountered abnormal tissue growth of the anterior
mediastinal compartment. Lymphatic and germinal
tumors are the second most frequent. Thymic tumors
are usually epithelial in origin, with low-grade neoplasm
and slow growth rate. The propensity of a thymoma to
be malignant is determined by the invasiveness of the
thymoma. Thus, thymomas without local invasion are
considered benign tumors. Other tumors include para-
thyroid, thyroid tissue, vascular, and mesenchymal tissue
masses. Occasionally, thymic tumors can be found in
the posterior mediastinum or other locations like lower
neck. Calcification can occur in benign and malignant
thymomas and up to 40 percent of thymomas present
with some type of calcifications [1]. In this review, we
will go over types of thymoma calcifications and their
clinical significance.
Epidemiology
Thymoma is a rare neoplasm that account for approxi-
mately 0.2-1.5% of all malignant neoplasms. Among the
anterior mediastinal tumors, thymoma is the most fre-
quent. It represents 20% of all mediastinal neoplasm in
adults [2,3]. Thymoma usually affects patients in the mid-
dle age with no sex predominance. About 35 percent of
thymic tumors are malignant with the exception of
patients between the ages of 20 to 40 where cancers
account for about half of thymic tumors. Thymoma
occurs with increasing frequency as age increases. It goes
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from 3% at age of 20 to about 12% at ages 21 to 45 years.
About 35 percent of thymic tumors occur after 46 years
of age [4]. Men and women are equally affected [5]. Thy-
moma is usually discovered incidentally on chest imaging
studies performed for other reasons. Approximately 50%
of thymomas are asymptomatic at the time of diagnosis.
Depending on study groups, the frequency of thymomas
with calcification ranges from 10% to 41% [1,6] and in
cases of invasive thymomas, it can go up to 54% [1].
Among other forms of calcifications found in thymoma,
small foci of calcification are the most common. Thy-
moma with massive calcification is uncommon and when
present, it is usually called dystrophic calcification.
Clinical Presentation
Approximately half of patients are asymptomatic at the
time of thymoma diagnosis and are incidental findings
[7]. In general, an approximate of 55% of patients with
benign mediastinal tumors is asymptomatic. Contrary,
only about 15% of those in whom tumors are found to be
malignant are asymptomatic. When symptomatic, sys-
temic symptoms related to tumor-related syndromes like
myasthenia gravis are predominant. Symptomatic thymo-
mas are usually invasive with local compression. In other
cases, dyspnea, cough and chest pain can be the present-
ing symptoms [8]. In the presence of an anterior mediast-
inal lesion, the diagnosis of thymoma is usually clinically
suspected based on the presence of myasthenia gravis or
other associated syndromes such as autoimmune or
immune diseases, endocrine abnormalities and syndrome
of inappropriate anti-diuretic hormone (SIADH) [9].
There were no previous reports correlating thymoma cal-
cifications to any specific symptoms.
Imaging Manifestations
As the configuration of the thymus gland changes with
age, imaging is expected to change as well. In the pre-
puberty period, the thymus attenuation on CT scan is
proportionate to that of the adjacent musculature. The
thymus lobes are usually separated with slight rotation
to the left from the midline. As the thymus becomes
infiltrated with fatty tissues, the attenuation starts to
recede compared to surrounding musculature. After the
age of 30, the thymus gland remnants appear as insular
areas of low attenuation soft tissue. They are usually
surrounded by higher attenuation fatty tissue. As we get
older, the thymus gland is seen as a thin fibrous tissue
with total deposition of fat. As the configuration of the
thymus gland may change from person to person
depending on various factors, the most dependable and
concise radiologic way to evaluate the thymus is by its
thickness.
Computed tomography (CT) scanning is the most
admired test for the diagnosis of thymoma and other
anterior mediastinal lesions. On computed tomography
(CT) and magnetic resonance imaging (MRI), most thy-
momas appear as spherical or ovoid lesions [10]. They
are usually well defined, lobulated, heterogeneous, and
located in the anterior-superior mediastinum. Although
most thymomas are homogenous attenuation lesions,
they may appear as soft-tissue masses that contain
regions of low attenuation, which could be secondary to
necrosis. On CT imaging, the areas of calcification and
hemorrhage are characterized by high attenuation densi-
ties [3,10]. Irregularities are usually the signs of local
invasion and aggressive carcinomas [3,11]. The most
reliable and meaningful measurements of the thymus
are related to its thickness. Although the normal thick-
ness before the age of 20 can be up to 1.8 cm, normal
thymus thickness in adults should not exceed 1 cm. Lar-
ger size, irregular contours, necrotic or cystic areas, and
foci of calcification, in addition to heterogeneous density
on CT scan, are likely signs of invasive thymoma [12].
Calcification was found more notably in invasive thy-
moma [1,13].
In small series, all patients with thymoma and calcifi-
cations were malignant [13,14]. However, calcification
per se cannot differentiate between benign and malig-
nant thymomas [15]. In a study for CT scan and pathol-
ogy correlation, Jung et al. identified thymoma
calcifications in one third of patients with high risk thy-
moma and in 61% of patients with thymic carcinoma
[16]. Thymoma may present as egg shell in the chest
[17] and in some cases, it can be hard to differentiate
from hemangioma [18]. At times, thymic cysts may pre-
sent as ring-like calcified lesions. Rarely, linear calcifica-
tions in the cyst wall are found. The typical water
density on the CT scan differentiates thymic cysts from
thymoma. Other mediastinal pathologies may display
calcifications. These lesions can have focal areas of calci-
fications upon diagnosis, like thymic carcinoma, med-
iastinal seminoma, thymic carcinoid tumors, and
hemangioma [3,19]. Tumors of the sternum can present
a challenge when considering the diagnosis of thymoma.
Radiologically, vascular lesions and other bone tumors
arising from the sternum may be comparable to thy-
moma, which make it difficult to differentiate between
these tumors. Scattered calcifications have been reported
in thymic amyloid tumors as well [20]. Moreover, med-
iastinal calcifications have been associated with other
lesions like germ cell tumors, including mature tera-
toma, thyroid tumors, mesothelioma, lymphoma, and
other anterior rare mediastinal lesions such as mesench-
ymal tumors [4]. In cases of lymphoma, calcifications are
sporadic and they often occur at about 7-8 months after
the onset of treatment [21]. The combinations of fluid,
soft and fatty components, which may also include oss-
eous or dental elements, support the diagnosis of mature
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teratoma [3]. Occasionally, mediastinal goiter can present
with coarse, punctuate or ring like-calcifications.
Positron emission tomography (PET) scan can be
helpful in the evaluation of tumor extension [22]. Thy-
mic carcinoma has higher uptake than other better dif-
ferentiated thymic epithelial tumors, as well as normal
or hyperplastic thymus [23]. Using an SUV cut-off point
of 5.0 high sensitivity (84.6%) and specificity (92.3%) can
be achieved when trying to distinguish between thymic
carcinoma and thymoma [24]. Finally, Thymomas
uncommonly show calcifications at chest radiography,
and when present, the patterns typically seen include
curvilinear or punctuate calcifications [3,4,19]. Plain film
can demonstrate amorphous, flocculent calcification. In
some cases, rim calcified thymomas can be clearly iden-
tified on plain film. Thymoma with rim calcification is
rare and this type of calcification has been described in
association with benign cystic thymoma [4]. Table 1
summarizes the studies and reported cases describing
the percentage of thymoma calcifications. The revised
World Health Organization (WHO) in 2004 classified
thymomas based on morphology and ratio of lympho-
cytes to epithelial cells. There were 6 categories, A, AB,
and B1 are the low risk thymoma, and B2 and B3 are
the high risk thymoma. The sixth category is the thymic
carcinoma. Thymus calcification was more frequently
seen in type B1, B2 and B3 thymomas. It was less fre-
quent in type AB and in thymic carcinoma (previously
classified as type C) [25,26]. A high degree of homoge-
neous enhancement has the propensity to indicate low
risk thymoma (type A or AB).
Histopathology
Pathological diagnosis can be very difficult as there is no
clear histological distinction between benign and malig-
nant thymomas. Therefore, definite diagnosis requires
surgical excision of the thymoma. Signs of malignancy
are local invasion through the capsule and to the
surrounding tissues. Malignant thymomas can invade
the adjacent structures including vasculature and lym-
phatics. The Masaoka staging system of thymomas is
the most commonly accepted system, with stage I when
the tumor is encapsulated, and stage IV with evidence
of metastatic spread. In general, a thymoma is deemed
malignant when gross or microscopic tumor invasion,
recurrence, or distant metastases are present [3]. Macro-
scopically, invasive thymomas may resemble to have an
intact capsule, and histologic examination is required to
confirm the diagnosis. On occasions, prominent macro-
scopic invasion may be apparent [27]. Larger size
thymomas are more likely to exhibit calcifications,
hemorrhage and cystic changes [27,28]. Oftentimes,
Thymomas is diagnosed in association with other condi-
tions, of which myasthenia gravis is the most common
[3]. Calcification in thymomas in association with
myasthenia gravis has been stated in 7-25% of patients
[3,4,19]. However, diagnosis from only imaging findings
is of limited value in differentiating the various histolo-
gic subtypes of thymomas [29].
Management
Surgery is the mainstay of therapy, and all thymomas,
except completely encapsulated stage I tumors, benefit
from adjuvant radiation therapy [22]. Recurrence rates
after surgical excision varies between 8 - 29% depending
on the series and type of tumour [30]. Local invasion
and distant tumor spread have been found to be the
most significant factor for survival [31]. In cases of inva-
sive thymoma, the leading causes of death are cardiore-
spiratory complications including cardiac tamponade.
The prognosis of patients with a thymoma is based on
the tumor’s gross characteristics at operation, not the his-
tological appearance. In case of invasive carcinoma, the
15-year survival rate is 12.5 percent, and 5 years survival
is about 35 percent. It is 47 percent for patients with a
noninvasive thymoma [22]. Medullary and lymphocyte
thymoma have the best survival, which is about 85
percent at 5 years [32]. Recently, we had a patient who
presented with a plain chest film showing 5 × 2.5 cm
anterior mediastinal mass which exhibits rim-like calcifi-
cations of the mass (Figure 1). Computed tomography
Table 1 Summary of studies and reported cases
describing the percentage of calcifications in patients







Tomiyama et al. 26 54 -
Sone et al. 0 40 -
Doe et al. - 17 10
Jung et al. - 33 61
Priola et al. 9 43 -
Jeong et al. 10 31 20
Figure 1 Frontal chest radiograph shows a rim calcified lesion
(left panel). Lateral chest radiography confirms that the rim
calcified mass resides within the anterior mediastinum (right panel).
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(CT) of the chest showed 4 × 3 cm rim calcified mini-
mally lobulated anterior mediastinal mass with predomi-
nantly solid internal contents with adjacent soft tissue
lesion in the anterior mediastinum (Figure 2). The chest
CT was followed by Positron emission tomography (PET)
scan which showed a 3.9 cm rim calcified right anterior
mediastinal mass. The mass was 18F-fluoro-2- deoxyglu-
cose (FDG) avid with standard uptake value (SUV) of 6.
The adjacent midline anterior mediastinal lesion was
FDG avid with SUV of 3.9 as well, suspicious for biologic
tumor activity (Figures 3). Robotic assisted surgery was
performed with excision of the entire calcified lesion.
The excised tissue was 10.4 × 5.6 × 2.8 cm calcified, lobu-
lated tissue weighing 40 grams. Pathological diagnosis
was consistent with thymoma, type B2, with microscopic
transcapsular invasion (Figure 4). The surgical margin
was negative and the thymoma was classified as modified
Masaoka stage IIa.
Conclusion
When anterior mediastinal lesion is suspected or diag-
nosed as thymoma, calcification doesn’t seem to have
any significantly meaningful diagnostic or prognostic
value. All study groups were retrospective with small
samples. Although the presence of thymus calcifications
was more common in invasive thymomas, they were
present in significant portion of non-invasive thymomas.
The presence of calcifications was not useful in differen-
tiating between benign and malignant thymoma. Even in
cases that present as rim-calcified tumors, invasive thy-
momas are still possible and one should proceed with
more sophisticated workup such as PET scan and subse-
quently, pathological diagnosis. Therefore, type, location,
size or other characteristics of thymus gland calcifica-
tions were not important factors in clinical and radio-
logic diagnosis of thymoma. The histopathological
diagnosis is still the gold standard to confirm the neo-
plastic nature of thymoma. All types of thymomas
should be evaluated and managed independently of the
Figure 2 Computed tomography (CT) scan showing a 3.9 cm
rim calcified right anterior mediastinal mass. CT with
intravenous contrast (right panel) shows the mass in relation to
mediastinal vasculature.
Figure 3 PET/CT scan: 2 views showing the 3.9 cm rim calcified right anterior mediastinal mass which is FDG avid (SUV 6). The
adjacent midline anterior mediastinal density is FDG avid as well (SUV 3.9).
Figure 4 Thymoma with lobular growth pattern and invasion
into mediastinal fat (hematoxylin-eosin, original magnification
X40).
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presence of calcifications. Thymoma is a rare entity
which precludes the initiation of large prospective trial.
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